Anthony Petrone
Stock Analyst at Mizuho
(3.68)
# 808
Out of 4,996 analysts
193
Total ratings
48.2%
Success rate
7.69%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $65 → $70 | $60.03 | +16.61% | 3 | Sep 25, 2025 | |
| ALC Alcon | Maintains: Outperform | $120 → $110 | $73.92 | +48.81% | 10 | Aug 21, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $48.17 | +45.32% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $50.61 | +38.31% | 6 | Aug 7, 2025 | |
| RMD ResMed | Maintains: Outperform | $270 → $290 | $270.27 | +7.30% | 17 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $119.99 | +12.51% | 9 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $87 → $95 | $76.25 | +24.59% | 9 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $133.55 | +1.09% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $67.55 | +33.23% | 15 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $26.80 | -32.84% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $100 | $94.22 | +6.13% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $70 | $67.21 | +4.15% | 9 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $39.11 | +78.98% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $13.90 | -13.67% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $67.10 | +49.03% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $79.92 | +118.97% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.46 | +334.78% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $12.00 | +66.67% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $53.57 | +12.00% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $56.29 | +3.04% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $53.44 | +12.28% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $98.18 | +12.04% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $15.61 | -10.31% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $72.46 | +44.91% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $77.24 | +223.67% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.94 | +101.73% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $441.12 | -11.59% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $84.19 | -20.42% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $98.24 | +78.14% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $12.06 | +107.30% | 3 | May 13, 2020 |
Guardant Health
Sep 25, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $60.03
Upside: +16.61%
Alcon
Aug 21, 2025
Maintains: Outperform
Price Target: $120 → $110
Current: $73.92
Upside: +48.81%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $48.17
Upside: +45.32%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $50.61
Upside: +38.31%
ResMed
Aug 1, 2025
Maintains: Outperform
Price Target: $270 → $290
Current: $270.27
Upside: +7.30%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $119.99
Upside: +12.51%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $87 → $95
Current: $76.25
Upside: +24.59%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $133.55
Upside: +1.09%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $67.55
Upside: +33.23%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $26.80
Upside: -32.84%
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $94.22
Upside: +6.13%
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $67.21
Upside: +4.15%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $39.11
Upside: +78.98%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $13.90
Upside: -13.67%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $67.10
Upside: +49.03%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $79.92
Upside: +118.97%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.46
Upside: +334.78%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $12.00
Upside: +66.67%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $53.57
Upside: +12.00%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $56.29
Upside: +3.04%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $53.44
Upside: +12.28%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $98.18
Upside: +12.04%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $15.61
Upside: -10.31%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $72.46
Upside: +44.91%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $77.24
Upside: +223.67%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.94
Upside: +101.73%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $441.12
Upside: -11.59%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $84.19
Upside: -20.42%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $98.24
Upside: +78.14%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $12.06
Upside: +107.30%